A detailed history of F Dx Advisors, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, F Dx Advisors, Inc. holds 3,780 shares of JNJ stock, worth $543,753. This represents 0.17% of its overall portfolio holdings.

Number of Shares
3,780
Previous 3,062 23.45%
Holding current value
$543,753
Previous $448,000 36.83%
% of portfolio
0.17%
Previous 0.12%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$145.48 - $167.38 $104,454 - $120,178
718 Added 23.45%
3,780 $613,000
Q2 2024

Aug 02, 2024

SELL
$144.38 - $157.78 $2,598 - $2,840
-18 Reduced 0.58%
3,062 $448,000
Q1 2024

May 03, 2024

SELL
$155.22 - $162.74 $2.93 Million - $3.07 Million
-18,865 Reduced 85.96%
3,080 $487,000
Q4 2023

Feb 12, 2024

SELL
$145.6 - $158.88 $443,934 - $484,425
-3,049 Reduced 12.2%
21,945 $3.44 Million
Q3 2023

Nov 02, 2023

SELL
$155.75 - $174.48 $1.34 Million - $1.51 Million
-8,626 Reduced 25.66%
24,994 $3.89 Million
Q2 2023

Jul 17, 2023

SELL
$154.35 - $166.11 $2.41 Million - $2.6 Million
-15,630 Reduced 31.74%
33,620 $5.56 Million
Q4 2022

Feb 09, 2023

SELL
$160.2 - $179.79 $187,594 - $210,534
-1,171 Reduced 2.32%
49,250 $8.7 Million
Q3 2022

Nov 10, 2022

BUY
$161.33 - $179.52 $24,683 - $27,466
153 Added 0.3%
50,421 $8.24 Million
Q2 2022

Aug 03, 2022

SELL
$168.19 - $186.01 $150,866 - $166,850
-897 Reduced 1.75%
50,268 $8.92 Million
Q1 2022

May 03, 2022

BUY
$158.14 - $179.59 $796,393 - $904,415
5,036 Added 10.92%
51,165 $9.07 Million
Q4 2021

Feb 01, 2022

BUY
$155.93 - $173.01 $1.15 Million - $1.28 Million
7,394 Added 19.09%
46,129 $7.89 Million
Q3 2021

Oct 08, 2021

BUY
$161.5 - $179.47 $437,826 - $486,543
2,711 Added 7.53%
38,735 $6.26 Million
Q2 2021

Aug 05, 2021

BUY
$159.48 - $171.07 $317,684 - $340,771
1,992 Added 5.85%
36,024 $5.94 Million
Q1 2021

Apr 14, 2021

BUY
$153.07 - $170.48 $4.35 Million - $4.85 Million
28,439 Added 508.47%
34,032 $5.59 Million
Q1 2021

Apr 13, 2021

SELL
$153.07 - $170.48 $5.18 Million - $5.77 Million
-33,853 Reduced 85.82%
5,593 $919,000
Q4 2020

Feb 08, 2021

SELL
$137.11 - $157.38 $1.99 Million - $2.29 Million
-14,531 Reduced 26.92%
39,446 $6.21 Million
Q3 2020

Nov 12, 2020

BUY
$140.38 - $153.83 $711,445 - $779,610
5,068 Added 10.36%
53,977 $8.04 Million
Q2 2020

Jul 22, 2020

SELL
$128.81 - $155.51 $240,745 - $290,648
-1,869 Reduced 3.68%
48,909 $6.88 Million
Q1 2020

May 22, 2020

BUY
$111.14 - $153.99 $4.53 Million - $6.27 Million
40,719 Added 404.8%
50,778 $6.66 Million
Q1 2020

May 13, 2020

SELL
$111.14 - $153.99 $4.2 Million - $5.82 Million
-37,798 Reduced 78.98%
10,059 $17,000
Q4 2019

Feb 12, 2020

BUY
$127.5 - $146.44 $1.06 Million - $1.22 Million
8,312 Added 21.02%
47,857 $6.98 Million
Q3 2019

Nov 07, 2019

SELL
$126.95 - $142.14 $2.81 Million - $3.14 Million
-22,119 Reduced 35.87%
39,545 $5.12 Million
Q2 2019

Jul 19, 2019

BUY
$131.15 - $144.24 $254,824 - $280,258
1,943 Added 3.25%
61,664 $8.59 Million
Q1 2019

May 14, 2019

BUY
$125.72 - $139.79 $1.9 Million - $2.11 Million
15,125 Added 33.92%
59,721 $8.35 Million
Q4 2018

Apr 29, 2019

SELL
$122.84 - $147.84 $10.9 Million - $13.1 Million
-88,338 Reduced 66.45%
44,596 $5.76 Million
Q4 2018

Feb 07, 2019

BUY
$122.84 - $147.84 $6.82 Million - $8.21 Million
55,509 Added 71.69%
132,934 $17.2 Million
Q3 2018

Nov 13, 2018

BUY
$121.58 - $142.88 $655,437 - $770,266
5,391 Added 7.48%
77,425 $10.7 Million
Q2 2018

Aug 08, 2018

SELL
$119.4 - $131.76 $2.71 Million - $2.99 Million
-22,679 Reduced 23.94%
72,034 $8.74 Million
Q1 2018

May 02, 2018

SELL
$125.1 - $148.14 $431,469 - $510,934
-3,449 Reduced 3.51%
94,713 $12.1 Million
Q4 2017

Feb 09, 2018

SELL
$131.22 - $143.62 $5.36 Million - $5.87 Million
-40,837 Reduced 29.38%
98,162 $13.7 Million
Q3 2017

Nov 03, 2017

BUY
$129.47 - $135.38 $375,592 - $392,737
2,901 Added 2.13%
138,999 $18.1 Million
Q2 2017

Aug 11, 2017

BUY
N/A
136,098
136,098 $18 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $376B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track F Dx Advisors, Inc. Portfolio

Follow F Dx Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on F Dx Advisors, Inc. with notifications on news.